Acrospire Investment Management LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q4 2016$71,000
-10.1%
8,820
-1.4%
0.03%
-45.3%
Q3 2016$79,000
+21.5%
8,944
+8.9%
0.05%
+10.4%
Q2 2016$65,000
+490.9%
8,215
+331.2%
0.05%
+500.0%
Q1 2016$11,0001,9050.01%
Other shareholders
RECRO PHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders